CARULLI, Nicola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.826
EU - Europa 8.387
AS - Asia 6.930
SA - Sud America 813
AF - Africa 137
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
Totale 30.120
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.657
SE - Svezia 2.337
SG - Singapore 2.207
CN - Cina 2.048
IT - Italia 1.874
GB - Regno Unito 1.832
HK - Hong Kong 822
DE - Germania 655
VN - Vietnam 608
BR - Brasile 596
FI - Finlandia 377
UA - Ucraina 330
TR - Turchia 318
FR - Francia 302
RU - Federazione Russa 241
KR - Corea 198
BD - Bangladesh 196
IN - India 139
BG - Bulgaria 124
AR - Argentina 85
CA - Canada 73
NL - Olanda 64
MX - Messico 54
IQ - Iraq 52
ID - Indonesia 51
JP - Giappone 46
ZA - Sudafrica 38
IE - Irlanda 35
AE - Emirati Arabi Uniti 34
CH - Svizzera 30
PL - Polonia 30
VE - Venezuela 28
EC - Ecuador 25
ES - Italia 25
CO - Colombia 24
TW - Taiwan 24
BE - Belgio 22
CZ - Repubblica Ceca 22
MY - Malesia 21
CL - Cile 19
MA - Marocco 19
PH - Filippine 19
PK - Pakistan 19
UZ - Uzbekistan 19
AT - Austria 15
EG - Egitto 14
KE - Kenya 14
SA - Arabia Saudita 14
CR - Costa Rica 12
PT - Portogallo 12
AU - Australia 11
JO - Giordania 11
PE - Perù 11
PY - Paraguay 11
AZ - Azerbaigian 10
NP - Nepal 10
DO - Repubblica Dominicana 9
DZ - Algeria 9
IL - Israele 9
IR - Iran 9
RO - Romania 9
BO - Bolivia 8
EU - Europa 8
ET - Etiopia 7
LT - Lituania 7
TN - Tunisia 7
NG - Nigeria 6
OM - Oman 6
PA - Panama 6
BH - Bahrain 5
LU - Lussemburgo 5
SI - Slovenia 5
UY - Uruguay 5
AL - Albania 4
GE - Georgia 4
HU - Ungheria 4
KG - Kirghizistan 4
KZ - Kazakistan 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
RS - Serbia 4
SN - Senegal 4
TH - Thailandia 4
UG - Uganda 4
AM - Armenia 3
AO - Angola 3
BY - Bielorussia 3
HR - Croazia 3
JM - Giamaica 3
KW - Kuwait 3
LB - Libano 3
LV - Lettonia 3
MK - Macedonia 3
CY - Cipro 2
GA - Gabon 2
GH - Ghana 2
GR - Grecia 2
HN - Honduras 2
KH - Cambogia 2
MD - Moldavia 2
Totale 30.089
Salva come PNG Salva come JPEG
Città #
Stockholm 1.787
Singapore 1.494
Santa Clara 1.264
Southend 1.147
Ashburn 1.092
Fairfield 1.030
Hong Kong 809
Woodbridge 789
Jacksonville 725
Chandler 721
Hefei 689
Houston 619
San Jose 560
Dearborn 492
Ann Arbor 469
Seattle 378
Chicago 377
Wilmington 375
Beijing 370
Cambridge 360
Nyköping 346
Los Angeles 308
London 300
Helsinki 229
The Dalles 209
Ho Chi Minh City 189
Seoul 185
Izmir 182
New York 171
Milan 163
Hanoi 157
Salt Lake City 144
Princeton 128
Modena 124
San Diego 123
Sofia 120
Eugene 115
Des Moines 111
Council Bluffs 109
Munich 103
Rome 101
Lauterbourg 96
Shanghai 93
Tampa 87
Buffalo 82
Grafing 73
Elk Grove Village 71
Dallas 69
Moscow 69
São Paulo 60
Columbus 57
Orem 50
Bremen 48
Bologna 46
Falls Church 46
Sterling 37
Naples 36
Boardman 34
Turin 34
Guangzhou 33
Dublin 32
Bari 31
Tokyo 31
Turku 30
Baghdad 29
Kunming 29
Lancaster 27
Napoli 27
Frankfurt am Main 26
Palermo 26
Da Nang 25
Kent 25
Redwood City 25
Brooklyn 24
Chennai 24
Florence 24
Warsaw 24
Mexico City 23
Phoenix 23
Jakarta 22
Miami 22
Torino 22
Haiphong 21
Brussels 20
Montreal 20
San Mateo 20
Atlanta 19
Brno 19
Nanjing 19
Amsterdam 18
Catania 18
Rio de Janeiro 18
Toronto 18
Verona 18
Parma 17
Falkenstein 16
Sondrio 16
Zhengzhou 16
Dhaka 14
Fremont 14
Totale 21.177
Salva come PNG Salva come JPEG
Nome #
"Assay of HMG-CoA reductase activity in the evaluation of cholesterol synthesis in man". 2.047
Le basi scientifiche dell'approccio bio-psico-sociale. Indicazioni per l'acquisizione delle competenze mediche appropriate 1.631
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 450
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 422
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 414
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 409
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 405
Effect of liver cirrhosis on the systemic availability of naltrexone in humans 399
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 386
Review article: diabetes, genetics and ethnicity 368
Characteristics of patients in a ward of Academic Internal Medicine. Implications for medical care, training programs and research 350
Herpesvirus DNA is frequently detected in liver tissue from hepatitis C patients 348
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 341
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 335
Growth of human herpesvirus 6 in HepG2 cells 324
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 322
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 322
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 309
Comparative cytotoxic and cytoprotective effects of taurohyodeoxycholic acid (THDCA) and tauroursodeoxycholic acid (TUDCA) in HepG2 cell line. 307
Factors associated with gallstone disease in the MICOL experience 307
Regulation of bile acid synthesis in humans: effect of treatment with bile acids, cholestyramine or simvastatin on cholesterol 7 alpha-hydroxylation rates in vivo. 298
Liver and kidney foreign bodies granulomatosis in a patient with malocclusion, bruxism, and worn dental prostheses 298
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 291
'Endocrine NAFLD' a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis 288
Advances in the comprehension of the pathophysiology of bile secretion 285
Chicken or egg turned into head or belly 282
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 282
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 279
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 274
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question 273
Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus - A prospective, double-blind, randomized study 272
Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study 268
Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.) 268
Effects of acute changes of bile acid pool composition on biliary lipid secretion 267
Bile acid structure and regulation of biliary protein secretion and composition in man 265
Effect of ursocholic acid on bile lipid secretion and composition 262
Effect of taurohyodeoxycholic acid on biliary lipid secretion in humans 260
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 259
Determinants of bile secretion: effect of bile salt structure on bile flow and biliary cation secretion 258
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 257
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 254
Growth hormone plasma levels in nonalcoholic fatty liver disease 249
Intestinal solubilization, absorption, pharmacokinetics and bioavailability of chenodeoxycholic acid. 246
Influence of age and sex on serum concentrations of total dimeric activin A 243
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 239
Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease 237
Review article: hyperlipidaemia and cardiovascular risk 237
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 236
Effect of diabetic autonomic neuropathy on gallbladder kinetics in insulin dependent diabetic patients 234
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 234
BILE CHANGES DURING TREATMENT WITH DEOXYCHOLIC-ACID - REPLY 232
Effect of small doses of deoxycholic acid on bile cholesterol saturation in patients with liver cirrhosis 232
Fecal neutral steroids in normal conditions and in patients with polyps or cancer of the large bowel 229
In vivo evaluation of cholesterol 7 alpha-hydroxylation in humans: effect of disease and drug treatment 228
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 228
Bile acid and hepatocyte death 226
HCV and diabetes. A two-question-based reappraisal. 221
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 217
Effect of aging on cholesterol 7 alpha-hydroxylation in humans 215
Regolazione della sintesi di colesterolo e acidi biliari 214
Statins and HCV: a complex issue 214
Effects of different phenotypes of hyperlipoproteinemia and of treatment with fibric acid derivatives on the rates of cholesterol 7alpha-hydroxylation in humans 211
Dysmetabolic changes associated with HCV: a distinct syndrome? 210
Nuclear receptors and obstructive cholestasis in Humans: increased heaptic expression of short heterodimer partner : a protective response? 209
Fatty liver, carotid disease and gallstones: A study ofage-related associations 209
TYPE 2 DIABETES AND CARDIOVASCULAR EVENTS : STUDY OF THE AMIN RISK FACTORS IN A LOCAL POPULATION OF PATIENTS 201
Cirrosi criptogenetiche. Un report di 5 pazienti 199
Olanzapine-induced hypertriglyceridemia and Diabetes mellitus 197
Effect of acute administration of bile acids on fatty acid composition of biliary phosphatidylcholine in man 197
EFFECT OF FISH OIL AND COCONUT OIL DIET ON THE LDL RECEPTOR ACTIVITY OF RAT LIVER PLASMA MEMBRANES. 196
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 195
Concurrent non-alcoholic steatohepatitis and psoriasis. Report of three cases from the POLI.ST.E.N.A. study. 195
The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease 193
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 193
Reply 193
Prevalence rates of gallstone disease in Italy: the Chianciano population study 189
Acute abdomen associated with schistosomiasis of the appendix 189
Cholestatic icterus: is there still a role for the clinic? 187
Chronic hepatopathies: from cryptogenetics to multiple factors 184
Hepatitis C and steatosis: a reappraisal 184
EFFECT OF CHENODEOXYCHOLIC ACID AND URSODEOXYCHOLIC ACID ADMINISTRATION ON ACYL-COA - CHOLESTEROL ACYLTRANSFERASE ACTIVITY IN HUMAN LIVER 184
Regulation of bile acid synthesis in humans: studies on cholesterol 7alpha-hydroxylation 'in vivo' 183
Patogenesi della colelitiasi 182
Colelitiasi sintomatica: affiorano dubbi sulla necessita' dell'intervento. 181
Complications following percutaneous liver biopsy: a multicenter retrospective study on 68.276 biopsies 178
Ursodeoxycholic acid improves liver tests in chronic hepatitis - Results of a randomised controlled trial 177
Risk for cardiovascular events in a local population of diabetic patients 177
Patogenesi ed epidemiologia della steatosi epatica e della steatoepatite non alcolica (NASH). 173
Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report. 172
Effects of bile acid pool composition on hepatic metabolism of cholesterol in man 171
Nuove prospettive terapeutiche con acidi biliari. 170
Structure and concentartion of differenty fatty acid (FFAS) affect steatosis extent and apoptosis in hepatocytes coltures 170
Should nonalcoholic fatty liver disease be renamed? 169
RISK FOR CARDIOVASCULAR EVENTS IN A LOCAL POPULATION OF DIABETIC PATIENTS 166
Tipologia dei ricoveri negli Ospedali Universitari: l'impatto sulle attività istituzionali 165
Gallstone dissolution. 164
Dietary cholesterol absorption in cirrhosis: the role of total and individual bile acid pool size. 161
Bile acids and cholesterol metabolism: Effect of deoxycholic acid on plasma lipoprotein and biliary cholesterol concentration 161
Epidemiologia e storia naturale dell'epatopatia steatosica non alcolica 160
Dislipidemie.In Teodori 2004. Trattato italiano di medicina interna 158
Totale 27.700
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.300
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202191 0 0 0 0 0 0 0 0 0 0 0 91
2021/20222.156 70 273 194 200 54 114 155 118 229 125 365 259
2022/20232.135 235 218 135 210 241 379 59 185 270 31 89 83
2023/20241.387 72 68 66 108 267 131 182 178 45 49 84 137
2024/20254.750 181 92 104 315 988 599 381 219 442 176 550 703
2025/202611.162 514 441 706 1.119 2.023 735 1.139 377 2.575 804 580 149
Totale 30.189